Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948

PG Gillespie and JA Beavo

Department of Pharmacology, University of Washington, Seattle 98195.

Few high affinity inhibitors of the photoreceptor phosphodiesterases have been identified. We show here that dipyridamole and M&B 22,948 (Zaprinast), potent inhibitors of the cGMP-binding, cGMP-specific phosphodiesterase (PDE), also inhibit trypsin- or transducin-activated bovine rod and cone photoreceptor phosphodiesterases at submicromolar concentrations. Dixon plots demonstrated that the inhibition of trypsin- activated rod PDE was competitive, with Ki values of 140 nM for M&B 22,948 and 380 nM for dipyridamole. Both of these drugs were much more potent than other PDE inhibitors, including isobutylmethylxanthine (IBMX). These results reinforce the suggestion that the photoreceptor and the cGMP-binding, cGMP-specific PDE are closely related. In addition, the high affinity and selectivity of these agents should make them useful for probing the regulation and function of PDE in the photoreceptor. At low substrate concentrations, the effects of these drugs on basal unactivated PDE activity were similar to those seen with trypsin- or transducin-activated PDE. At millimolar substrate concentrations, however, the effects of the drugs were biphasic; PDE activity was stimulated at drug concentrations from 1 to 10 microM and inhibited at higher concentrations. Stimulation was not observed with IBMX. This stimulation of activity apparently was not an allosteric effect caused by direct binding of the dipyridamole and M&B 22,948 to the high affinity noncatalytic cGMP binding sites on the PDEs; whereas no cooperativity of cGMP binding to this site has been demonstrated, the drugs actually stimulated the binding of low concentrations of cGMP to this site. In addition, whereas preincubation with cGMP and cGMP analogs blocked the stimulation exerted by the drugs, they did so only at much higher concentrations than those necessary for saturation of the high affinity noncatalytic cGMP site. Because the stimulation can only be seen at higher substrate levels than are thought to exist in the photoreceptor, only the inhibitory effects of the drugs are likely to be pharmacologically relevant. However, the stimulation exerted by these drugs may point to a hitherto unknown allosteric interaction between the catalytic and regulatory sites on the PDE or to a previously unrecognized regulatory site.

Volume 36, Issue 5, pp. 773-781, 11/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. Sato, N. Hida, and Y. Umezawa Imaging the nanomolar range of nitric oxide with an amplifier-coupled fluorescent indicator in living cells PNAS, October 11, 2005; 102(41): 14515 - 14520. [Abstract] [Full Text] [PDF]

				X. Zhang, Q. Feng, and R. H. Cote Efficacy and Selectivity of Phosphodiesterase-Targeted Drugs in Inhibiting Photoreceptor Phosphodiesterase (PDE6) in Retinal Photoreceptors Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3060 - 3066. [Abstract] [Full Text] [PDF]

				D. Holcman and J. I. Korenbrot The Limit of Photoreceptor Sensitivity: Molecular Mechanisms of Dark Noise in Retinal Cones J. Gen. Physiol., May 31, 2005; 125(6): 641 - 660. [Abstract] [Full Text] [PDF]

				K. G. Muradov, K. K. Boyd, S. E. Martinez, J. A. Beavo, and N. O. Artemyev The GAFa Domains of Rod cGMP-phosphodiesterase 6 Determine the Selectivity of the Enzyme Dimerization J. Biol. Chem., March 14, 2003; 278(12): 10594 - 10601. [Abstract] [Full Text] [PDF]

				B. Aktas, A. Utz, P. Hoenig-Liedl, U. Walter, and J. Geiger Dipyridamole Enhances NO/cGMP-Mediated Vasodilator-Stimulated Phosphoprotein Phosphorylation and Signaling in Human Platelets: In Vitro and In Vivo/Ex Vivo Studies Stroke, March 1, 2003; 34(3): 764 - 769. [Abstract] [Full Text] [PDF]

				B. Trivedi and R. H. Kramer Patch Cramming Reveals the Mechanism of Long-Term Suppression of Cyclic Nucleotides in Intact Neurons J. Neurosci., October 15, 2002; 22(20): 8819 - 8826. [Abstract] [Full Text] [PDF]

				M. d. P. Gomez and E. Nasi Light Transduction in Invertebrate Hyperpolarizing Photoreceptors: Possible Involvement of a Go-Regulated Guanylate Cyclase J. Neurosci., July 15, 2000; 20(14): 5254 - 5263. [Abstract] [Full Text] [PDF]

				L. E. Fox and P. E. Lloyd Role of cAMP in the Short-Term Modulation of a Neuromuscular System in Aplysia J Neurophysiol, March 1, 2000; 83(3): 1567 - 1579. [Abstract] [Full Text] [PDF]

				L. Santschi, M. Reyes-Harde, and P. K. Stanton Chemically Induced, Activity-Independent LTD Elicited by Simultaneous Activation of PKG and Inhibition of PKA J Neurophysiol, September 1, 1999; 82(3): 1577 - 1589. [Abstract] [Full Text] [PDF]

				H. Mou, H. J. Grazio III, T. A. Cook, J. A. Beavo, and R. H. Cote cGMP Binding to Noncatalytic Sites on Mammalian Rod Photoreceptor Phosphodiesterase Is Regulated by Binding of Its gamma  and delta  Subunits J. Biol. Chem., June 25, 1999; 274(26): 18813 - 18820. [Abstract] [Full Text] [PDF]

				M. R. D'Amours, A. E. Granovsky, N. O. Artemyev, and R. H. Cote Potency and Mechanism of Action of E4021, a Type 5 Phosphodiesterase Isozyme-Selective Inhibitor, on the Photoreceptor Phosphodiesterase Depend on the State of Activation of the Enzyme Mol. Pharmacol., March 1, 1999; 55(3): 508 - 514. [Abstract] [Full Text]

				W. Liu, W. A. Clark, P. Sharma, and J. K. Northup Mechanism of Allosteric Regulation of the Rod cGMP Phosphodiesterase Activity by the Helical Domain of Transducin alpha  Subunit J. Biol. Chem., December 18, 1998; 273(51): 34284 - 34292. [Abstract] [Full Text] [PDF]

				W. Liu and J. K. Northup The helical domain of a G protein alpha  subunit is a regulator of its effector PNAS, October 27, 1998; 95(22): 12878 - 12883. [Abstract] [Full Text] [PDF]

				A. E. Granovsky, M. Natochin, R. L. McEntaffer, T. L. Haik, S. H. Francis, J. D. Corbin, and N. O. Artemyev Probing Domain Functions of Chimeric PDE6alpha '/PDE5 cGMP-Phosphodiesterase J. Biol. Chem., September 18, 1998; 273(38): 24485 - 24490. [Abstract] [Full Text] [PDF]

				I. V. Turko, S. H. Francis, and J. D. Corbin Potential Roles of Conserved Amino Acids in the Catalytic Domain of the cGMP-binding cGMP-specific Phosphodiesterase (PDE5) J. Biol. Chem., March 13, 1998; 273(11): 6460 - 6466. [Abstract] [Full Text] [PDF]

				M. C. Hebert, F. Schwede, B. Jastorff, and R. H. Cote Structural Features of the Noncatalytic cGMP Binding Sites of Frog Photoreceptor Phosphodiesterase Using cGMP Analogs J. Biol. Chem., March 6, 1998; 273(10): 5557 - 5565. [Abstract] [Full Text] [PDF]

				M. R. Maclean, E. D. Johnston, K. M. Mcculloch, L. Pooley, M. D. Houslay, and G. Sweeney Phosphodiesterase Isoforms in the Pulmonary Arterial Circulation of the Rat: Changes in Pulmonary Hypertension J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 619 - 624. [Abstract] [Full Text]

				A. E. Granovsky, M. Natochin, and N. O. Artemyev The gamma  Subunit of Rod cGMP-Phosphodiesterase Blocks the Enzyme Catalytic Site J. Biol. Chem., May 2, 1997; 272(18): 11686 - 11689. [Abstract] [Full Text] [PDF]

				H. Rarick, N. Artemyev, and H. Hamm A site on rod G protein alpha subunit that mediates effector activation Science, May 15, 1992; 256(5059): 1031 - 1033. [Abstract] [PDF]

				A. E. Granovsky and N. O. Artemyev Identification of the gamma Subunit-interacting Residues on Photoreceptor cGMP Phosphodiesterase, PDE6alpha ' J. Biol. Chem., December 22, 2000; 275(52): 41258 - 41262. [Abstract] [Full Text] [PDF]

				A. E. Granovsky and N. O. Artemyev Partial Reconstitution of Photoreceptor cGMP Phosphodiesterase Characteristics in cGMP Phosphodiesterase-5 J. Biol. Chem., June 8, 2001; 276(24): 21698 - 21703. [Abstract] [Full Text] [PDF]